Teva Pharmaceutical Industries (TEVA) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $481.0 million.
- Teva Pharmaceutical Industries' Profit After Tax rose 27490.91% to $481.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.4 billion, marking a year-over-year increase of 17072.32%. This contributed to the annual value of $1.4 billion for FY2025, which is 17238.39% up from last year.
- Latest data reveals that Teva Pharmaceutical Industries reported Profit After Tax of $481.0 million as of Q4 2025, which was up 27490.91% from $434.0 million recorded in Q3 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Profit After Tax registered a high of $1.7 billion during Q4 2023, and its lowest value of -$1.3 billion during Q4 2022.
- Moreover, its 5-year median value for Profit After Tax was -$44.5 million (2021), whereas its average is -$101.0 million.
- Per our database at Business Quant, Teva Pharmaceutical Industries' Profit After Tax crashed by 123690.48% in 2022 and then soared by 27490.91% in 2025.
- Teva Pharmaceutical Industries' Profit After Tax (Quarter) stood at -$152.0 million in 2021, then tumbled by 776.97% to -$1.3 billion in 2022, then soared by 227.31% to $1.7 billion in 2023, then plummeted by 116.21% to -$275.0 million in 2024, then soared by 274.91% to $481.0 million in 2025.
- Its Profit After Tax was $481.0 million in Q4 2025, compared to $434.0 million in Q3 2025 and $283.0 million in Q2 2025.